AAAAAA

   
Results: 1-9 |
Results: 9

Authors: MERLE PA THEIJSMEIJER P JANSSEN JJWM OSSENKOPPELE GJ VANOOSTVEEN JW
Citation: Pa. Merle et al., MULTIPLEX RT-PCR DOES NOT DISTINGUISH BETWEEN A BCR-ABL TRANSCRIPT LACKING ABL EXON A2 (ALL) AND B2A2 TRANSCRIPTS (CML), British Journal of Haematology, 102(1), 1998, pp. 110-110

Authors: VERVOORDELDONK SF MERLE PA BEHRENDT H STEENBERGEN EJ VANDENBERG H VANWERING ER VONDEMBORNE AEGK VANDERSCHOOT CE VANLEEUWEN EF SLAPERCORTENBACH ICM
Citation: Sf. Vervoordeldonk et al., PCR-POSITIVITY IN HARVESTED BONE-MARROW PREDICTS RELAPSE AFTER TRANSPLANTATION WITH AUTOLOGOUS PURGED BONE-MARROW IN CHILDREN IN 2ND REMISSION OF PRECURSOR B-CELL ACUTE-LEUKEMIA, British Journal of Haematology, 96(2), 1997, pp. 395-402

Authors: VERVOORDELDONK SF HEIKENS J GOEDEMANS WT MERLE PA VONDEMBORNE AEGK VANROYEN EA SLAPERCORTENBACH ICM VANOERS RHJ
Citation: Sf. Vervoordeldonk et al., TC-99M-CD19 MONOCLONAL-ANTIBODY IS NOT USEFUL FOR IMAGING OF B-CELL NON-HODGKINS-LYMPHOMA, Cancer immunology and immunotherapy, 42(5), 1996, pp. 291-296

Authors: VERVOORDELDONK SF MERLE PA BEHRENDT H STEENBERGEN EJ VANLEEUWEN EF VANDENBERG H VONDEMBORNE AEGK VANDERSCHOOT CE SLAPERCORTENBACH ICM
Citation: Sf. Vervoordeldonk et al., TRIPLE IMMUNOFLUORESCENCE STAINING FOR PREDICTION OF RELAPSE IN CHILDHOOD PRECURSOR-B ACUTE LYMPHOBLASTIC-LEUKEMIA, British Journal of Haematology, 92(4), 1996, pp. 922-928

Authors: STEENBERGEN EJ VERHAGEN OJHM VANLEEUWEN EF BEHRENDT H MERLE PA WESTER MR VONDEMBORNE AEGK VANDERSCHOOT CE
Citation: Ej. Steenbergen et al., B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA 3RD COMPLEMENTARITY-DETERMINING REGIONS PREDOMINANTLY REPRESENT AN UNBIASED RECOMBINATION REPERTOIRE - LEUKEMIC TRANSFORMATION FREQUENTLY OCCURS IN FETAL LIFE, European Journal of Immunology, 24(4), 1994, pp. 900-908

Authors: VERVOORDELDONK SF MERLE PA VANLEEUWEN EF VONDEMBORNE AEGK SLAPERCORTENBACH ICM
Citation: Sf. Vervoordeldonk et al., PRECLINICAL STUDIES WITH RADIOLABELED MONOCLONAL-ANTIBODIES FOR TREATMENT OF PATIENTS WITH B-CELL MALIGNANCIES, Cancer, 73(3), 1994, pp. 1006-1011

Authors: VERVOORDELDONK SF MERLE PA VANLEEUWEN EF VANDERSCHOOT CE VONDEMBORNE AEGK SLAPERCORTENBACH ICM
Citation: Sf. Vervoordeldonk et al., FC-GAMMA RECEPTOR-II (CD32) ON MALIGNANT B-CELLS INFLUENCES MODULATION INDUCED BY ANTI-CD19 MONOCLONAL-ANTIBODY, Blood, 83(6), 1994, pp. 1632-1639

Authors: VERVOORDELDONK SF MERLE PA VANLEEUWEN EF VANDERSCHOOT CE VONDEMBORNE AEGK SLAPERCORTENBACH ICM
Citation: Sf. Vervoordeldonk et al., THE INFLUENCE OF FC-GAMMA-RECEPTOR EXPRESSION ON MALIGNANT B-CELLS ONANTIGEN MODULATION IN MONOCLONAL-ANTIBODY THERAPY, Experimental hematology, 21(8), 1993, pp. 1116-1116

Authors: VERVOORDELDONK SF MERLE PA VANLEEUWEN EF VANDERSCHOOT CE VONDEMBORNE AEGK SLAPERCORTENBACH ICM
Citation: Sf. Vervoordeldonk et al., TRIPLE IMMUNOFLUORESCENCE STAINING FOR DETECTION OF MINIMAL RESIDUAL DISEASE IN CHILDREN WITH COMMON ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 82(10), 1993, pp. 10000551-10000551
Risultati: 1-9 |